DE19528145A1 - Neue Arzneimittel und ihre Verwendung - Google Patents

Neue Arzneimittel und ihre Verwendung

Info

Publication number
DE19528145A1
DE19528145A1 DE19528145A DE19528145A DE19528145A1 DE 19528145 A1 DE19528145 A1 DE 19528145A1 DE 19528145 A DE19528145 A DE 19528145A DE 19528145 A DE19528145 A DE 19528145A DE 19528145 A1 DE19528145 A1 DE 19528145A1
Authority
DE
Germany
Prior art keywords
hydroxy
inhalative
agents
pharmaceutical preparations
salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19528145A
Other languages
German (de)
English (en)
Inventor
Rolf Dr Banholzer
Richard Dr Reichl
Bernd Dr Dr Disse
Georg Dr Speck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim GmbH
Original Assignee
Boehringer Ingelheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim GmbH filed Critical Boehringer Ingelheim GmbH
Priority to DE19528145A priority Critical patent/DE19528145A1/de
Priority to TW085108367A priority patent/TW449597B/zh
Priority to YU44596A priority patent/YU49479B/sh
Priority to CZ19962253A priority patent/CZ291998B6/cs
Priority to HU9602104A priority patent/HU228056B1/hu
Priority to PCT/EP1996/003364 priority patent/WO1997005136A1/de
Priority to NZ315645A priority patent/NZ315645A/xx
Priority to SK112-98A priority patent/SK283260B6/sk
Priority to MYPI96003140A priority patent/MY115201A/en
Priority to IL11898696A priority patent/IL118986A/en
Priority to RO98-00142A priority patent/RO120260B1/ro
Priority to RU98103895/04A priority patent/RU2171258C2/ru
Priority to EE9800028A priority patent/EE04614B1/xx
Priority to UA98021045A priority patent/UA55391C2/uk
Priority to ZA966494A priority patent/ZA966494B/xx
Priority to AU67397/96A priority patent/AU6739796A/en
Priority to PT96927638T priority patent/PT843676E/pt
Priority to PL96324804A priority patent/PL183789B1/pl
Priority to TR1998/00121T priority patent/TR199800121T1/xx
Priority to SI9630405T priority patent/SI0843676T1/xx
Priority to BR9609951A priority patent/BR9609951A/pt
Priority to HR960365A priority patent/HRP960365B1/xx
Priority to CO96040544A priority patent/CO4750836A1/es
Priority to JP9507251A priority patent/JPH11510150A/ja
Priority to ARP960103824A priority patent/AR004179A1/es
Priority to KR10-1998-0700661A priority patent/KR100445016B1/ko
Priority to EP96927638A priority patent/EP0843676B1/de
Priority to CA002226934A priority patent/CA2226934C/en
Priority to CN96195701A priority patent/CN1120841C/zh
Priority to MX9800864A priority patent/MX9800864A/es
Priority to ES96927638T priority patent/ES2167592T3/es
Priority to DE59608156T priority patent/DE59608156D1/de
Priority to DK96927638T priority patent/DK0843676T3/da
Priority to AT96927638T priority patent/ATE208390T1/de
Publication of DE19528145A1 publication Critical patent/DE19528145A1/de
Priority to BG102202A priority patent/BG63780B1/bg
Priority to NO19980424A priority patent/NO317561B1/no
Priority to HK98111418A priority patent/HK1013597A1/xx
Priority to HK98112141A priority patent/HK1010879A1/xx
Priority to US09/369,711 priority patent/US6299861B1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE19528145A 1995-08-01 1995-08-01 Neue Arzneimittel und ihre Verwendung Withdrawn DE19528145A1 (de)

Priority Applications (39)

Application Number Priority Date Filing Date Title
DE19528145A DE19528145A1 (de) 1995-08-01 1995-08-01 Neue Arzneimittel und ihre Verwendung
TW085108367A TW449597B (en) 1995-08-01 1996-07-10 Pharmaceutical compositions with anticholinergic activity
YU44596A YU49479B (sh) 1995-08-01 1996-07-29 Preparati koji sadrže enantiomer ipratropijum bromida sa produženim aktivnim dejstvom
CZ19962253A CZ291998B6 (cs) 1995-08-01 1996-07-30 Farmaceutický prostředek
SI9630405T SI0843676T1 (en) 1995-08-01 1996-07-31 Preparations containing ipratropium bromide enantiomer with a prolonged duration of action
JP9507251A JPH11510150A (ja) 1995-08-01 1996-07-31 長期間持続性作用を有する臭化イプラトピウムエナンチオマー
NZ315645A NZ315645A (en) 1995-08-01 1996-07-31 Ipratropium bromide enantiomer with a prolonged duration of action
SK112-98A SK283260B6 (sk) 1995-08-01 1996-07-31 Farmaceutický prostriedok s obsahom solí (endo,syn)-(-)-(3- hydroxy-1-oxo-2-fenylpropoxy)-8-metyl-8-(1-metyletyl)-8- azoniabicyklo[3,2,1]oktánu a jeho použitie
MYPI96003140A MY115201A (en) 1995-08-01 1996-07-31 Preparations containing ipratropium bromide enantiomer with a prolonged duration of action
IL11898696A IL118986A (en) 1995-08-01 1996-07-31 Optically pure epitropium salts and pharmaceutical preparations containing them
RO98-00142A RO120260B1 (ro) 1995-08-01 1996-07-31 Compoziţii farmaceutice pentru inhalare, pe bază de săruri de ipratropiu şi utilizarea acestora
RU98103895/04A RU2171258C2 (ru) 1995-08-01 1996-07-31 Бромид l-(-)-энантиомера(эндо,син)-(-)-3-(3-окси-1-оксо-2-фенилпропокси)-8-метил- 8-(1-метилэтил)-8-азони-абицикло[3.2.1]октана с чистотой 90-100% и ингаляционный препарат для ингибирования бронхоспазма, вызванного ацетилхолином
EE9800028A EE04614B1 (et) 1995-08-01 1996-07-31 Inhaleeritav farmatseutiline preparaat, selles sisalduvate iprotroopiumisoolade kasutamine ja iprotroopiumisool
UA98021045A UA55391C2 (uk) 1995-08-01 1996-07-31 Бромід l-(-)-енантіомера (ендо, син)-(-)-3-(3-оксі-1-оксо-2-фенілпропокси)-8-метил-8-(1-метилетил)-8-азоніабіцикло[3.2.1]октану з чистотою 90-100% та інгаляційний препарат для інгібування бронхоспазму, викликаного ацетилхоліном
ZA966494A ZA966494B (en) 1995-08-01 1996-07-31 New drugs and their use
AU67397/96A AU6739796A (en) 1995-08-01 1996-07-31 Ipratropium bromide enantiomer with a prolonged duration of action
PT96927638T PT843676E (pt) 1995-08-01 1996-07-31 Preparacoes medicamentosas contendo um enanteomero de brometo de ipratropio com duracao de accao prolongada
PL96324804A PL183789B1 (pl) 1995-08-01 1996-07-31 Kompozycje farmaceutyczne o przedłużonym działaniu, sposób ich wytwarzania i bromek (endo,syn)-(-)-3-(3-hydroksy-1-okso-2-fenylopropoksy) 8-metylo-8-(1-metyloetylo)-8-azonia bicyklo [3,2,1] oktanu
TR1998/00121T TR199800121T1 (xx) 1995-08-01 1996-07-31 Uzat�lm�� etki s�resine sahip ipratropyumbromid'in bir enantiyomeri.
HU9602104A HU228056B1 (en) 1995-08-01 1996-07-31 Preparations containing ipratropium salts enantiomer with a prolonged duration of action
BR9609951A BR9609951A (pt) 1995-08-01 1996-07-31 Novas composições farmacêuticas e seu uso
HR960365A HRP960365B1 (en) 1995-08-01 1996-07-31 New medicaments and the use thereof
CO96040544A CO4750836A1 (es) 1995-08-01 1996-07-31 Nuevos medicamentos y utilizacion (1-metiletil)-8-azoniabiciclo-[3.2.1]octnao y su uso en pre- paraciones medicas
PCT/EP1996/003364 WO1997005136A1 (de) 1995-08-01 1996-07-31 Ein enantiomer von ipratropiumbromid mit verlängerter wirkungsdauer
ARP960103824A AR004179A1 (es) 1995-08-01 1996-07-31 Sales de (endo,sin)-(-)-3-(3-hidroxi-1-oxo-2-fenilpropoxi)-8-metil-8-(1- metiletil)-8-azoniabiciclo[3.2.1] octano y preparaciones medicamentosasinhalativas que las contienen.
KR10-1998-0700661A KR100445016B1 (ko) 1995-08-01 1996-07-31 활성이장기간지속되는(엔도,신)-(-)-3-(3-하이드록시-1-옥소-2-페닐프로폭시)-8-메틸-8-(1-메틸에틸)-8-아조니아비사이클로[3,2,1]옥탄의l-(-)-에난티오머의염및이를포함하는약제학적제제
EP96927638A EP0843676B1 (de) 1995-08-01 1996-07-31 Arzneimittelvorbereitungen enthaltend ein enantiomer von ipratropiumbromid mit verlängerter wirkungsdauer
CA002226934A CA2226934C (en) 1995-08-01 1996-07-31 Ipratropium bromide enantiomer with a prolonged duration of action
CN96195701A CN1120841C (zh) 1995-08-01 1996-07-31 新颖药物组合物及其用途
MX9800864A MX9800864A (es) 1995-08-01 1996-07-31 Nuevos medicamentos y su utilizacion.
ES96927638T ES2167592T3 (es) 1995-08-01 1996-07-31 Preparaciones medicamentosas que contienen un enantiomero de bromuro de ipratropio con duracion de la accion prolongada.
DE59608156T DE59608156D1 (de) 1995-08-01 1996-07-31 Arzneimittelvorbereitungen enthaltend ein enantiomer von ipratropiumbromid mit verlängerter wirkungsdauer
DK96927638T DK0843676T3 (da) 1995-08-01 1996-07-31 Præparater indeholdende ipratropiumbromidenantiomer med en forlænget virkningsvarighed
AT96927638T ATE208390T1 (de) 1995-08-01 1996-07-31 Arzneimittelvorbereitungen enthaltend ein enantiomer von ipratropiumbromid mit verlängerter wirkungsdauer
BG102202A BG63780B1 (bg) 1995-08-01 1998-01-20 Енантиомер на ипратропиев бромид с удължено действие
NO19980424A NO317561B1 (no) 1995-08-01 1998-01-30 Ipratropiumbromid-enantiomer med forlenget virkningstid
HK98111418A HK1013597A1 (en) 1995-08-01 1998-10-21 Preparations containing ipratropium bromide enantiomer with a prolonged duration of action
HK98112141A HK1010879A1 (en) 1995-08-01 1998-11-20 Ipratropium bromide enantiomer with a prolonged duration of action
US09/369,711 US6299861B1 (en) 1995-08-01 1999-08-06 Ipratropium bromide enantiomer with prolonged duration of effect

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19528145A DE19528145A1 (de) 1995-08-01 1995-08-01 Neue Arzneimittel und ihre Verwendung

Publications (1)

Publication Number Publication Date
DE19528145A1 true DE19528145A1 (de) 1997-02-06

Family

ID=7768353

Family Applications (2)

Application Number Title Priority Date Filing Date
DE19528145A Withdrawn DE19528145A1 (de) 1995-08-01 1995-08-01 Neue Arzneimittel und ihre Verwendung
DE59608156T Expired - Lifetime DE59608156D1 (de) 1995-08-01 1996-07-31 Arzneimittelvorbereitungen enthaltend ein enantiomer von ipratropiumbromid mit verlängerter wirkungsdauer

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE59608156T Expired - Lifetime DE59608156D1 (de) 1995-08-01 1996-07-31 Arzneimittelvorbereitungen enthaltend ein enantiomer von ipratropiumbromid mit verlängerter wirkungsdauer

Country Status (37)

Country Link
US (1) US6299861B1 (zh)
EP (1) EP0843676B1 (zh)
JP (1) JPH11510150A (zh)
KR (1) KR100445016B1 (zh)
CN (1) CN1120841C (zh)
AR (1) AR004179A1 (zh)
AT (1) ATE208390T1 (zh)
AU (1) AU6739796A (zh)
BG (1) BG63780B1 (zh)
BR (1) BR9609951A (zh)
CA (1) CA2226934C (zh)
CO (1) CO4750836A1 (zh)
CZ (1) CZ291998B6 (zh)
DE (2) DE19528145A1 (zh)
DK (1) DK0843676T3 (zh)
EE (1) EE04614B1 (zh)
ES (1) ES2167592T3 (zh)
HK (2) HK1013597A1 (zh)
HR (1) HRP960365B1 (zh)
HU (1) HU228056B1 (zh)
IL (1) IL118986A (zh)
MX (1) MX9800864A (zh)
MY (1) MY115201A (zh)
NO (1) NO317561B1 (zh)
NZ (1) NZ315645A (zh)
PL (1) PL183789B1 (zh)
PT (1) PT843676E (zh)
RO (1) RO120260B1 (zh)
RU (1) RU2171258C2 (zh)
SI (1) SI0843676T1 (zh)
SK (1) SK283260B6 (zh)
TR (1) TR199800121T1 (zh)
TW (1) TW449597B (zh)
UA (1) UA55391C2 (zh)
WO (1) WO1997005136A1 (zh)
YU (1) YU49479B (zh)
ZA (1) ZA966494B (zh)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19921693A1 (de) * 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
US20100197719A1 (en) * 1999-05-12 2010-08-05 Boehringer Ingelheim Pharma Kg Medicament compositions containing anticholinergically-effective compounds and betamimetics
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
US6777400B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6787532B2 (en) 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
GB0019172D0 (en) 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
US6858593B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6777399B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6858596B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6750210B2 (en) 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
US20020151541A1 (en) * 2000-10-31 2002-10-17 Michel Pairet Pharmaceutical compositions containing tiotropium salts and antihistamines and their use
US7776315B2 (en) * 2000-10-31 2010-08-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and additional active ingredients
US20100310477A1 (en) * 2000-11-28 2010-12-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg. Pharmaceutical compositions based on anticholingerics and additional active ingredients
UA77656C2 (en) 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
US6455028B1 (en) * 2001-04-23 2002-09-24 Pharmascience Ipratropium formulation for pulmonary inhalation
US20050070487A1 (en) * 2001-04-24 2005-03-31 Nyce Jonathan W. Composition, formulations and kit for treatment of respiratory and lung disease with non-glucocorticoid steroids and/or ubiquinone and a bronchodilating agent
US20030018019A1 (en) * 2001-06-23 2003-01-23 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics
US6702997B2 (en) 2001-10-26 2004-03-09 Dey, L.P. Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
US20030203930A1 (en) * 2001-10-26 2003-10-30 Imtiaz Chaudry Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
US20030140920A1 (en) * 2001-10-26 2003-07-31 Dey L.P. Albuterol inhalation soultion, system, kit and method for relieving symptoms of pediatric asthma
JP2003221335A (ja) 2001-10-26 2003-08-05 Dey Lp 慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、システム、キットおよび方法
US20030191151A1 (en) * 2001-10-26 2003-10-09 Imtiaz Chaudry Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
GB0202635D0 (en) * 2002-02-05 2002-03-20 Glaxo Wellcome Mfg Pte Ltd Formulation containing novel anti-inflammatory androstane derivative
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
US20050043343A1 (en) * 2003-07-28 2005-02-24 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising an anticholinergic and a PDE IV inhibitor
US20050026948A1 (en) * 2003-07-29 2005-02-03 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising an anticholinergic and a betamimetic
US20050026882A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
US20050101545A1 (en) * 2003-07-31 2005-05-12 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
US20090317476A1 (en) * 2003-07-31 2009-12-24 Robinson Cynthia B Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
US20050038004A1 (en) * 2003-07-31 2005-02-17 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
ES2257152B1 (es) * 2004-05-31 2007-07-01 Laboratorios Almirall S.A. Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos.
PE20060826A1 (es) * 2004-12-06 2006-10-08 Smithkline Beecham Corp Derivado oleofinico de 8-azoniabiciclo[3.2.1]octano y combinacion farmaceutica que lo comprende
WO2006114379A1 (de) * 2005-04-23 2006-11-02 Boehringer Ingelheim International Gmbh Arzneimittelkombination für die inhalation enthaltend neben einem anticholinergikum ein betamimetikum und ein steroid
US20060239935A1 (en) * 2005-04-23 2006-10-26 Boehringer Ingelheim International Gmbh Compositions for inhalation
EP2100598A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients
TW201311649A (zh) * 2011-09-05 2013-03-16 Everlight Chem Ind Corp 用於太陽能電池電解液之化合物及其製法、含有該化合物之電解液及太陽能電池
CN111751454B (zh) * 2019-03-29 2023-12-08 天津药业研究院股份有限公司 一种异丙托溴铵中间体i的含量和有关物质的检测方法
CN110361494B (zh) * 2019-06-26 2023-08-15 四川普锐特药业有限公司 异丙托溴铵气雾剂中杂质g的检测方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3505337A (en) * 1967-12-22 1970-04-07 Boehringer Sohn Ingelheim N - hydrocarbyl-substituted noratropinium,haloalkylates and o-acyl derivatives thereof
DE2903957A1 (de) * 1979-02-02 1980-08-07 Boehringer Sohn Ingelheim Mittel zur behandlung der nasalen hypersekretion
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
DE4140861C2 (de) * 1991-12-11 2003-12-11 Boehringer Ingelheim Kg Verfahren zur Gewinnung von quartären Tropasäurealkaloiden
WO1994013263A1 (en) * 1992-12-09 1994-06-23 Jager Paul D Stabilized medicinal aerosol solution formulations

Also Published As

Publication number Publication date
MX9800864A (es) 1998-04-30
TR199800121T1 (xx) 1998-04-21
CN1191535A (zh) 1998-08-26
NO980424L (no) 1998-01-30
EP0843676B1 (de) 2001-11-07
HU9602104D0 (en) 1996-09-30
US6299861B1 (en) 2001-10-09
NO317561B1 (no) 2004-11-15
RU2171258C2 (ru) 2001-07-27
PL324804A1 (en) 1998-06-22
CA2226934A1 (en) 1997-02-13
KR100445016B1 (ko) 2004-11-08
ES2167592T3 (es) 2002-05-16
PT843676E (pt) 2002-04-29
PL183789B1 (pl) 2002-07-31
CN1120841C (zh) 2003-09-10
HUP9602104A2 (en) 1997-04-28
HK1013597A1 (en) 1999-09-03
CZ291998B6 (cs) 2003-07-16
MY115201A (en) 2003-04-30
EP0843676A1 (de) 1998-05-27
NZ315645A (en) 1999-11-29
BG102202A (en) 1998-09-30
NO980424D0 (no) 1998-01-30
EE9800028A (et) 1998-08-17
IL118986A (en) 1998-12-06
DK0843676T3 (da) 2001-12-27
HK1010879A1 (en) 1999-07-02
ZA966494B (en) 1997-02-03
JPH11510150A (ja) 1999-09-07
SK11298A3 (en) 1998-07-08
BG63780B1 (bg) 2002-12-29
WO1997005136A1 (de) 1997-02-13
HRP960365A2 (en) 1998-02-28
BR9609951A (pt) 1999-02-02
RO120260B1 (ro) 2005-11-30
EE04614B1 (et) 2006-04-17
TW449597B (en) 2001-08-11
HUP9602104A3 (en) 2000-03-28
CO4750836A1 (es) 1999-03-31
ATE208390T1 (de) 2001-11-15
DE59608156D1 (de) 2001-12-13
SI0843676T1 (en) 2002-06-30
AU6739796A (en) 1997-02-26
KR19990035997A (ko) 1999-05-25
HRP960365B1 (en) 2002-04-30
YU49479B (sh) 2006-05-25
HU228056B1 (en) 2012-09-28
CZ225396A3 (cs) 1998-03-18
AR004179A1 (es) 1998-11-04
IL118986A0 (en) 1996-10-31
UA55391C2 (uk) 2003-04-15
YU44596A (sh) 1998-12-23
SK283260B6 (sk) 2003-04-01
CA2226934C (en) 2007-05-01

Similar Documents

Publication Publication Date Title
EP0843676B1 (de) Arzneimittelvorbereitungen enthaltend ein enantiomer von ipratropiumbromid mit verlängerter wirkungsdauer
EP1809243B1 (de) Aerosolsuspensionsformulierungen mit tg 227 ea als treibmittel
EP1408967B1 (de) ARZNEIMITTELKOMPOSITIONEN AUF DER BASIS VON Tiotropium, Ciclesonide UND einem BETAMIMETIKum ZUR BEHANDLUNG VON ENTZÜNDLICHEN UND/ODER OBSTRUKTIVEN ATEMWEGSERKRANKUNGEN
EP1335728B1 (de) Arzneimittelkompositionen auf der basis von tiotropiumsalzen und salzen des salmeterols
WO2000069468A1 (de) NEUARTIGE ARZNEIMITTELKOMPOSITIONEN AUF DER BASIS VON ANTICHOLINERGISCH WIRKSAMEN VERBINDUNGEN UND β-MIMETIKA
EP1682542B1 (de) Neues kristallines anhydrat mit anticholinerger wirksamkeit
DE10104367A1 (de) Betamimetika enthaltende Arzneimittelkompositionen mit geringeren Nebenwirkungen
DE602004005462T2 (de) Medikamente zur inhalation mit betamimetika und einem anticholinergikum
EP1492513B1 (de) Hfa-suspensionsformulierungen enthaltend ein anticholinergikum
DE10104370A1 (de) Arzneimittelkompositionen mit geringeren Nebenwirkungen
EP0341559A2 (de) Synergistische Kombinationen und ihre Verwendung als Therapeutika
DE102004032322A1 (de) Aerosolsuspensionsformulierungen mit TG 227 ea als Teibmittel
AU4381800A (en) Ipratropium bromide enantiomer with a prolonged duration of action
DE10209243A1 (de) Neue Arzneimittelkombination zur Inhalation
DE10145438A1 (de) Neue Arzneimittel zur Inhalation

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8139 Disposal/non-payment of the annual fee